Literature DB >> 16538533

No nodal cutoff in node-positive breast cancer women treated with mastectomy.

V Vinh-Hung1, G Storme.   

Abstract

PURPOSE: To search for a prognostic cutoff in the number of involved axillary lymph-nodes, in T1-T2 node-positive (N+) breast cancer treated with mastectomy without radiotherapy.
MATERIALS AND METHODS: Women aged 51-64 years presenting with a first primary T1-T2, N+, M0 unilateral carcinoma diagnosed in 1988-97 were selected from the SEER 9-registries. Cutoffs from 1 to 23 nodes were scanned with Cox models that included diagnostic year, age, area, race, marital status, histology, grade, hormone receptors, tumor location, size, and nodes examined. Outcomes were breast cancer specific and any-cause death.
RESULTS: The overall mortality hazard ratio of a higher number of involved nodes as compared with a lower number ranged from 1.78 [95% confidence 1.58-1.99] with 1-node cutoff, to 3.65 [2.52-5.29] with 23-nodes cutoff. Breast cancer specific mortality hazard ratio ranged from 1.99 [1.73-2.29] with 1-node cutoff, to 4.63 [3.11-6.91] with 23-nodes cutoff. The graph of the hazard ratios showed a continuously increasing risk of overall and breast cancer specific mortality, without any identifiable cutpoint change.
CONCLUSION: The results show no prognostic cutoff in the number of involved axillary lymph nodes in patients who did not receive radiotherapy. The rationale of nodal cutoff as an indicator for post-mastectomy adjuvant treatment in node-positive patients should be questioned.

Entities:  

Mesh:

Year:  2006        PMID: 16538533     DOI: 10.1007/s10549-005-9146-z

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  6 in total

1.  Age and axillary lymph node ratio in postmenopausal women with T1-T2 node positive breast cancer.

Authors:  Vincent Vinh-Hung; Sue A Joseph; Nadege Coutty; Bevan Hong Ly; Georges Vlastos; Nam Phong Nguyen
Journal:  Oncologist       Date:  2010-10-07

2.  The effect of adjuvant radiotherapy on mortality differs according to primary tumor location in women with node-positive breast cancer.

Authors:  Vincent Vinh-Hung; Pauline T Truong; Wolfgang Janni; Nam Phong Nguyen; Georges Vlastos; Gábor Cserni; Melanie E Royce; Wendy A Woodward; Donald Promish; Patricia Tai; Guy Soete; Sabine Balmer-Majno; Bruno Cutuli; Guy Storme; Christine Bouchardy
Journal:  Strahlenther Onkol       Date:  2009-03-28       Impact factor: 3.621

3.  Accurate staging of axillary lymph nodes from breast cancer patients using a novel molecular method.

Authors:  T Osako; T Iwase; K Kimura; K Yamashita; R Horii; F Akiyama
Journal:  Br J Cancer       Date:  2011-08-30       Impact factor: 7.640

4.  Recursive partitioning analysis of lymph node ratio in breast cancer patients.

Authors:  Yao-Jen Chang; Kuo-Piao Chung; Li-Ju Chen; Yun-Jau Chang
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

5.  Validation of a prognostic scoring system for postmastectomy locoregional recurrence in breast cancer.

Authors:  Aline Van der Vorst; Isabelle Kindts; Annouschka Laenen; Patrick Neven; Hilde Janssen; Caroline Weltens
Journal:  Breast       Date:  2022-04-18       Impact factor: 4.254

6.  Axillary Lymph Node Involvement in Breast Cancer: A Random Walk Model of Tumor Burden.

Authors:  Vincent Vinh-Hung; Nicolas Leduc; Jacqueline Baudin; Guy Storme; Nam P Nguyen; Clarisse Joachim; Elsa Cecilia-Joseph; Claire Verschraegen
Journal:  Cureus       Date:  2019-11-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.